Daniel Jon Sall

Person

Indianapolis, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
Selective estrogen receptor degraders
- Patent number 12,128,040
- Issue date Oct 29, 2024
- Eli Lilly and Company
- Jeffrey Daniel Cohen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective estrogen receptor degraders
- Patent number 11,993,608
- Issue date May 28, 2024
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective estrogen receptor degraders
- Patent number 11,634,426
- Issue date Apr 25, 2023
- Eli Lilly and Company
- Jolie Anne Bastian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective estrogen receptor degraders
- Patent number 11,117,902
- Issue date Sep 14, 2021
- Eli Lilly and Company
- Jolie Anne Bastian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1-tetrahydropyranylcarbonyl-2,3-dihydro-1H-indole compounds for tre...
- Patent number 10,759,786
- Issue date Sep 1, 2020
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective estrogen receptor degraders
- Patent number 10,654,866
- Issue date May 19, 2020
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolylaminobenzimidazole derivatives as JAK inhibitors
- Patent number 10,344,018
- Issue date Jul 9, 2019
- Eli Lilly and Company
- Jolie Anne Bastian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolylaminobenzimidazole derivatives as JAK inhibitors
- Patent number 10,323,019
- Issue date Jun 18, 2019
- Eli Lilly and Company
- Jolie Anne Bastian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2,3-dihydro-1H-indole compounds
- Patent number 9,872,853
- Issue date Jan 23, 2018
- Eli Lilly and Company
- Jolie Anne Bastian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrasubstituted pyridazine hedgehog pathway antagonists
- Patent number 8,507,490
- Issue date Aug 13, 2013
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrasubstituted pyridazines hedgehog pathway antagonists
- Patent number 8,445,493
- Issue date May 21, 2013
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Disubstituted phthalazine hedgehog pathway antagonists
- Patent number 8,404,687
- Issue date Mar 26, 2013
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Certain glycine derivatives as factor Xa inhibitors for use in the...
- Patent number 7,297,706
- Issue date Nov 20, 2007
- Eli Lilly and Company
- Michael Robert Wiley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds
- Patent number 7,294,627
- Issue date Nov 13, 2007
- Eli Lilly and Company
- Steven Douglas Hiscock
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
β3 adrenergic agonists
- Patent number 7,265,127
- Issue date Sep 4, 2007
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds
- Patent number 7,265,121
- Issue date Sep 4, 2007
- Eli Lilly and Company
- Michael Robert Wiley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
β3 adrenergic agonists
- Patent number 7,253,181
- Issue date Aug 7, 2007
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
β3 adrenergic agonists
- Patent number 7,241,772
- Issue date Jul 10, 2007
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
β3 adrenergic agonists
- Patent number 7,208,505
- Issue date Apr 24, 2007
- Eli Lilly and Company
- Daniel Jon Sall
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-Substituted oxindole β3 agonists
- Patent number 7,205,407
- Issue date Apr 17, 2007
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopenta[b]indole derivatives as sPLA2 inhibitors
- Patent number 7,160,909
- Issue date Jan 9, 2007
- Eli Lilly and Company
- Michael Dean Kinnick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-Substituted oxindole β3 agonsists
- Patent number 7,122,680
- Issue date Oct 17, 2006
- Eli Lilly and Company
- Cynthia Darshini Jesudason
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Alanyl-piperidine heterocyclic derivatives useful against cardiovas...
- Patent number 7,115,609
- Issue date Oct 3, 2006
- Eli Lilly and Company
- Stuart Donald Jones
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclohept[b]indole derivatives
- Patent number 7,109,231
- Issue date Sep 19, 2006
- Eli Lilly and Company
- Michael Dean Kinnick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-substituted oxindole β3 agonists
- Patent number 7,087,635
- Issue date Aug 8, 2006
- Eli Lilly and Company
- Daniel Jon Sall
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Certain glycine derivatives as factor Xa inhibitors for use in the...
- Patent number 7,078,415
- Issue date Jul 18, 2006
- Eli Lilly and Company
- Michael Robert Wiley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
β3 Adrenergic agonists
- Patent number 7,071,208
- Issue date Jul 4, 2006
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
sPLA2 inhibitors
- Patent number 6,992,100
- Issue date Jan 31, 2006
- Eli Lilly and Company
- Douglas Wade Beight
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
sPLA2 inhibitors
- Patent number 6,974,831
- Issue date Dec 13, 2005
- Eli Lilly and Company
- Douglas Wade Beight
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
sPLA2 inhibitors
- Patent number 6,930,123
- Issue date Aug 16, 2005
- Eli Lilly and Company
- Douglas Wade Beight
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SELECTIVE ESTROGEN RECEPTOR DEGRADERS
- Publication number 20230234960
- Publication date Jul 27, 2023
- Eli Lilly and Company
- Jolie Anne BASTIAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of treating cancer using a combination of SERD Dosing Regimens
- Publication number 20220288019
- Publication date Sep 15, 2022
- Eli Lilly and Company
- Shripad Venkatraman BHAGWAT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE ESTROGEN RECEPTOR DEGRADERS
- Publication number 20210403480
- Publication date Dec 30, 2021
- Eli Lilly and Company
- Jolie Anne BASTIAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE ESTROGEN RECEPTOR DEGRADERS
- Publication number 20210260052
- Publication date Aug 26, 2021
- Eli Lilly and Company
- Jeffrey Daniel COHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE ESTROGEN RECEPTOR DEGRADERS
- Publication number 20200347073
- Publication date Nov 5, 2020
- Eli Lilly and Company
- Jolie Anne BASTIAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE ESTROGEN RECEPTOR DEGRADERS
- Publication number 20200017516
- Publication date Jan 16, 2020
- Eli Lilly and Company
- Jolie Anne BASTIAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS
- Publication number 20190177300
- Publication date Jun 13, 2019
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1-TETRAHYDROPYRANYLCARBONYL-2,3-DIHYDRO-IH-INDOLE COMPOUNDS FOR TRE...
- Publication number 20190161477
- Publication date May 30, 2019
- Eli Lilly and Company
- Jolie Anne Bastian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS
- Publication number 20180325873
- Publication date Nov 15, 2018
- Eli Lilly and Company
- Jolie Anne Bastian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2,3-DIHYDRO-1H-INDOLE COMPOUNDS
- Publication number 20170354641
- Publication date Dec 14, 2017
- Eli Lilly and Company
- Jolie Anne Bastian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRASUBSTITUTED PYRIDAZINE HEDGEHOG PATHWAY ANTAGONISTS
- Publication number 20110263602
- Publication date Oct 27, 2011
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS
- Publication number 20110190304
- Publication date Aug 4, 2011
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRASUBSTITUTED PYRIDAZINES HEDGEHOG PATHWAY ANTAGONISTS
- Publication number 20110178093
- Publication date Jul 21, 2011
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CERTAIN GLYCINE DERIVATIVES AS FACTOR Xa INHIBITORS FOR USE IN THE...
- Publication number 20070072869
- Publication date Mar 29, 2007
- Michael Robert Wiley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BETA 3 ADRENERGIC AGONISTS
- Publication number 20060142328
- Publication date Jun 29, 2006
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BETA 3 ADRENERGIC AGONISTS
- Publication number 20060142327
- Publication date Jun 29, 2006
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BETA 3 ADRENERGIC AGONISTS
- Publication number 20060142329
- Publication date Jun 29, 2006
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-Substituted oxindole beta3 agonists
- Publication number 20050159473
- Publication date Jul 21, 2005
- Daniel Jon Sall
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Beta 3 adrenergic agonists
- Publication number 20050080110
- Publication date Apr 14, 2005
- Daniel Jon Sall
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-Substituted oxindole beta3 agonists
- Publication number 20050054713
- Publication date Mar 10, 2005
- Cynthia Darshini Jesudason
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chemical compounds
- Publication number 20050026928
- Publication date Feb 3, 2005
- Michael Robert Wiley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopenta'b! indole derivatives as spla inhibitors
- Publication number 20050026988
- Publication date Feb 3, 2005
- Michael Dean Kinnick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-substituted oxindole beta3 agonists
- Publication number 20050020617
- Publication date Jan 27, 2005
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Beta 3 adrenergic agonists
- Publication number 20050020618
- Publication date Jan 27, 2005
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Alanyl-piperidine heterocyclic derivatives useful against cardiovas...
- Publication number 20040254374
- Publication date Dec 16, 2004
- Stuart Donald Jones
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chemical compounds
- Publication number 20040249151
- Publication date Dec 9, 2004
- Steven Douglas Hiscock
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Certain glycine derivatives as factor xa inhibitors for use in the...
- Publication number 20040249155
- Publication date Dec 9, 2004
- Michael Robert Wiley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Beta3 adrenergic agonists
- Publication number 20040242633
- Publication date Dec 2, 2004
- Britta Evers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-substituted oxindole beta-3 agonists
- Publication number 20040242668
- Publication date Dec 2, 2004
- Daniel Jon Sall
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclohept'b!indole derivatives as spla2 inhibitors
- Publication number 20040198801
- Publication date Oct 7, 2004
- Michael Dean Kinnick
- C07 - ORGANIC CHEMISTRY

Daniel Jon Sall

Person

Patents Grantslast 30 patents

Selective estrogen receptor degraders

Selective estrogen receptor degraders

Selective estrogen receptor degraders

Selective estrogen receptor degraders

1-tetrahydropyranylcarbonyl-2,3-dihydro-1H-indole compounds for tre...

Selective estrogen receptor degraders

Pyrazolylaminobenzimidazole derivatives as JAK inhibitors

Pyrazolylaminobenzimidazole derivatives as JAK inhibitors

2,3-dihydro-1H-indole compounds

Tetrasubstituted pyridazine hedgehog pathway antagonists

Tetrasubstituted pyridazines hedgehog pathway antagonists

Disubstituted phthalazine hedgehog pathway antagonists

Certain glycine derivatives as factor Xa inhibitors for use in the...

Chemical compounds

β3 adrenergic agonists

Chemical compounds

β3 adrenergic agonists

β3 adrenergic agonists

β3 adrenergic agonists

3-Substituted oxindole β3 agonists

Cyclopenta[b]indole derivatives as sPLA2 inhibitors

3-Substituted oxindole β3 agonsists

Alanyl-piperidine heterocyclic derivatives useful against cardiovas...

Cyclohept[b]indole derivatives

3-substituted oxindole β3 agonists

Certain glycine derivatives as factor Xa inhibitors for use in the...

β3 Adrenergic agonists

sPLA2 inhibitors

sPLA2 inhibitors

sPLA2 inhibitors

Patents Applicationslast 30 patents

SELECTIVE ESTROGEN RECEPTOR DEGRADERS

Methods of treating cancer using a combination of SERD Dosing Regimens

SELECTIVE ESTROGEN RECEPTOR DEGRADERS

SELECTIVE ESTROGEN RECEPTOR DEGRADERS

SELECTIVE ESTROGEN RECEPTOR DEGRADERS

SELECTIVE ESTROGEN RECEPTOR DEGRADERS

PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS

1-TETRAHYDROPYRANYLCARBONYL-2,3-DIHYDRO-IH-INDOLE COMPOUNDS FOR TRE...

PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS

2,3-DIHYDRO-1H-INDOLE COMPOUNDS

TETRASUBSTITUTED PYRIDAZINE HEDGEHOG PATHWAY ANTAGONISTS

DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS

TETRASUBSTITUTED PYRIDAZINES HEDGEHOG PATHWAY ANTAGONISTS

CERTAIN GLYCINE DERIVATIVES AS FACTOR Xa INHIBITORS FOR USE IN THE...

BETA 3 ADRENERGIC AGONISTS

BETA 3 ADRENERGIC AGONISTS

BETA 3 ADRENERGIC AGONISTS

3-Substituted oxindole beta3 agonists

Beta 3 adrenergic agonists

3-Substituted oxindole beta3 agonists

Chemical compounds

Cyclopenta'b! indole derivatives as spla inhibitors

3-substituted oxindole beta3 agonists

Beta 3 adrenergic agonists

Alanyl-piperidine heterocyclic derivatives useful against cardiovas...

Chemical compounds

Certain glycine derivatives as factor xa inhibitors for use in the...

Beta3 adrenergic agonists

3-substituted oxindole beta-3 agonists

Cyclohept'b!indole derivatives as spla2 inhibitors